A novel series of low molecular weight immunosuppressive agents.
Ocain
T D
TD
Procept, Inc, Cambridge, MA 02139, USA.
Bastos
C M
CM
Gordon
K A
KA
Granstein
R D
RD
Jenson
J C
JC
Jones
B
B
McAuliffe
D J
DJ
Newcomb
J R
JR
D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D018801:CD2 Antigens / Q000276:immunology; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007376:Interleukin-2 / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects*; D051379:Mice; D008805:Mice, Inbred A; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009942:Organometallic Compounds / Q000737:chemistry / Q000494:pharmacology*; D011758:Pyrroles / Q000737:chemistry / Q000494:pharmacology*; D016038:Skin Transplantation / Q000276:immunology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D013997:Time Factors; D014184:Transplantation, Homologous
D000906:Antibodies; D018801:CD2 Antigens; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D009942:Organometallic Compounds; C102908:PRO 1556; C102909:PRO 2844B; D011758:Pyrroles; D016572:Cyclosporine